Media Contact
Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday:
- Andrea Greif
Senior Director, Communications
(914) 821-8958
andrea.greif@lls.org
Subaru and LLS Celebrate Gestures of Hope for Subaru Love Promise
Rye Brook, NY (May 31, 2016) – Subaru of America and The Leukemia & Lymphoma Society (LLS) announced a collaboration to provide much needed support and “warmth” to patients fighting cancer and their families in communities across the country. During Subaru Loves to Care month this June, LLS and participating Subaru retailers across the country together will provide blankets and messages of hope to ...
LLS Applauds Approval of New Therapy for CLL Patients
Rye Brook, NY – April 12, 2016 – The approval of a new therapy for patients with a high-risk form of chronic lymphocytic leukemia (CLL) is welcome news for patients for whom there have been few other options, The Leukemia & Lymphoma Society (LLS) said today. The U.S. Food and Drug Administration has approved venetoclax (Venclexta ®) to treat patients with a rare subset of CLL in which a piece of chromosom...
LLS Recognizes Volunteers During National Volunteer Week
Rye Brook, NY, April 11, 2016 – Volunteer led, staff driven. As the world’s leading voluntary non-profit fighting blood cancers, The Leukemia & Lymphoma Society (LLS) has set the bar in defining volunteerism and demonstrating impact. During National Volunteer Week, April 10-16, 2016, LLS would like to thank all its volunteers making an impact in advocacy, policy and patient access. “LLS has millio...
LLS Joins "Be Here Now" (The Andy Whitfield Story) Producers in Generating Awareness for Blood Cancers
Los Angeles, CA, April 4, 2016 – “Be Here Now” (The Andy Whitfield Story) and The Leukemia & Lymphoma Society (LLS) announced today their collaboration to spread awareness about the urgent need to find cures and ensure access to treatments for blood cancer patients. This news is timed to the U.S. theatrical release of this award winning feature documentary, about star, Andy Whitfield, of "Spartacu...
Walgreens and LLS Create New Approach to Support Cancer Patients in their Communities
Rye Brook, NY, and Deerfield, IL, March 16, 2016 - The Leukemia & Lymphoma Society (LLS) and Walgreen Co. today announced the launch of an innovative collaboration designed to further advance cancer therapies and address the changing treatment model facing patients with blood and other cancers. The collaboration, between LLS and Walgreens Specialty Pharmacy, builds on the heritage of Walgreens in serving its comm...
LLS Announces Progress Against Devastating Disease
White Plains, NY, March 14, 2016 – An investigational therapy supported by The Leukemia & Lymphoma Society (LLS) performed significantly better than the standard therapy in a Phase 3 clinical trial for patients with high-risk (secondary) acute myeloid leukemia (AML), its developer announced today. AML remains the deadliest of all blood cancers, and there have been no new therapies for nearly 40 ...
It Takes a Village: Thousands of Volunteers Join Campaign to Help Competing Candidates Raise Millions to Create a World Without Blood Cancer
White Plains, NY, March 14, 2016 – How do you cure cancer? You volunteer. A new survey by The Leukemia & Lymphoma Society (LLS), Giving and Getting Back: Volunteering in America, shows on average, three out of four people agree that giving time, giving money and actively participating in fundraising events are the most effective ways to support a charitable cause. For 10 weeks, in more than 80 cities acro...
Leading Researchers, Clinicians, Policy and Drug Development Experts, and Cancer Survivors Convene to Discuss Latest Advances and Challenges in Treating Blood Cancers
Click here for a comprehensive media toolkit. New York – February 25, 2016 – A panel of world renowned thought leaders from research, clinical practice, policymaking, pharmaceutical industry and patient advocacy convened today to discuss and debate the latest advances and insights into blood cancer research and treatment, drug costs and patient access, and patient advocacy and policy. The roundtable was organi...